A highly sensitive, low input, and automated assay for molecular residual disease detection (MRD) using whole-genome sequencing (WGS).Li Liu, Traci Pawlowski, Jeff H. Tsai et al.|Journal of Clinical Oncology|2024Cited by 0
Comparison of a highly sensitive, tumor-informed Illumina whole genome sequencing research assay and a tumor-informed bespoke whole exome sequencing assay for molecular residual disease detection in CheckMate-77T (NCT 04025879).Jonathan Beer, Traci Pawlowski, Jacob Gibson et al.|Journal of Clinical Oncology|2026Cited by 0